# Barbados Chemicals Export Opportunities (HS 28-38) ![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp) > Yugalinks sector export playbook Explore Barbados HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities. ## Overview - Exporter: Barbados (BRB) - Sector: Chemicals - HS chapters: HS 28-38 - Latest trade year: 2024 - Sector exports: $22.6M - Products: 24 - Buyer markets: 29 - Average CAGR: +26.9% - Global sector size: $438.0B ## Product portfolio | Product | Global size | Your exports | Opportunity | CAGR | Markets | Share | | --- | ---: | ---: | ---: | ---: | ---: | ---: | | HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $297.9B | $15.5M | $109.8B | +30.4% | 26 | +0.1% | | HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $9.6B | $17.7K | $12.1B | -18.3% | 5 | +0.0% | | HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $7.6B | $11.1K | $11.2B | +188.2% | 1 | +0.1% | | HS 300220 - Vaccines: for human medicine | $14.0B | $728.2 | $9.5B | +16.2% | 3 | +0.0% | | HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $8.5B | $910.3K | $9.4B | +96.2% | 1 | +6.9% | | HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $16.3B | $1.3K | $8.6B | -1.6% | 4 | +0.0% | | HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $19.9B | $63.9K | $8.2B | +12.5% | 5 | +0.0% | | HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $11.5B | $17.7K | $8.0B | +38.1% | 4 | +0.0% | | HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $16.8B | $39.3K | $6.8B | -6.7% | 6 | +0.0% | | HS 330300 - Perfumes and toilet waters | $8.5B | $423.8K | $4.4B | -9.6% | 3 | +0.0% | | HS 293590 - Sulphonamides: n.e.c. in heading no. 2935 | $1.6B | $112.4K | $3.1B | +250.9% | 1 | +2.6% | | HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $4.9B | $323.6 | $3.0B | -4.8% | 4 | +0.0% | | HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $5.0B | $33.0 | $2.6B | -17.8% | 2 | +0.0% | | HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $2.0K | $2.2B | +3.8% | 2 | +0.0% | | HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.3B | $154.6 | $2.1B | -2.6% | 2 | +0.0% | | HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $648.2M | $5.5M | $847.4M | +495.3% | 1 | +27.6% | | HS 300449 - Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $1.5B | $2.3K | $841.5M | +39.1% | 1 | +0.0% | | HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $2.1K | $803.3M | +7.2% | 1 | +0.0% | | HS 281410 - Ammonia: anhydrous | $1.1B | $351.0 | $748.4M | +130.2% | 1 | +0.0% | | HS 284440 - Radioactive elements, isotopes, compounds, n.e.c. in heading no. 2844 alloys, dispersions (including cermets), ceramic products and mixtures containing these elements, isotopes or compounds: radioactive residues | $927.2M | $123.6 | $685.2M | +4.6% | 1 | +0.0% | | HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $1.5B | $3.0K | $645.9M | +15.3% | 1 | +0.0% | | HS 340600 - Candles, tapers and the like | $1.0B | $6.4K | $640.8M | +23.3% | 1 | +0.0% | | HS 300660 - Pharmaceutical goods: chemical contraceptive preparations based on hormones or spermicides | $1.2B | $5.6K | $604.6M | +20.1% | 1 | +0.0% | | HS 330749 - Perfumes and deodorizors: perfuming or deodorizing preparations for rooms, (excluding those which operate by burning) | $676.1M | $68.2 | $579.1M | -6.6% | 1 | +0.0% | ## Best markets - USA, Puerto Rico and US Virgin Islands (USA): $56.8B calculated opportunity across 19 products. - Slovenia (SVN): $33.8B calculated opportunity across 5 products. - Switzerland, Liechtenstein (CHE): $28.3B calculated opportunity across 2 products. - Germany (DEU): $11.0B calculated opportunity across 6 products. - Canada (CAN): $9.8B calculated opportunity across 7 products. - United Kingdom (GBR): $9.5B calculated opportunity across 6 products. - China (CHN): $7.9B calculated opportunity across 2 products. - Belgium (BEL): $7.0B calculated opportunity across 1 products. - France (FRA): $6.6B calculated opportunity across 5 products. - Netherlands (NLD): $6.5B calculated opportunity across 3 products. - Italy (ITA): $4.9B calculated opportunity across 1 products. - Mexico (MEX): $4.8B calculated opportunity across 2 products. ## Growth stars - HS 293339: +495.3% average CAGR, $847.4M calculated opportunity. - HS 293590: +250.9% average CAGR, $3.1B calculated opportunity. - HS 293359: +188.2% average CAGR, $11.2B calculated opportunity. - HS 281410: +130.2% average CAGR, $748.4M calculated opportunity. - HS 293399: +96.2% average CAGR, $9.4B calculated opportunity. - HS 300449: +39.1% average CAGR, $841.5M calculated opportunity. - HS 382499: +38.1% average CAGR, $8.0B calculated opportunity. - HS 300490: +30.4% average CAGR, $109.8B calculated opportunity. - HS 340600: +23.3% average CAGR, $640.8M calculated opportunity. - HS 300660: +20.1% average CAGR, $604.6M calculated opportunity. ## Diversification opportunities - HS 300490: 26 buyer markets, $109.8B calculated opportunity. - HS 382200: 6 buyer markets, $6.8B calculated opportunity. - HS 330210: 5 buyer markets, $12.1B calculated opportunity. - HS 330499: 5 buyer markets, $8.2B calculated opportunity. - HS 300439: 4 buyer markets, $8.6B calculated opportunity. - HS 382499: 4 buyer markets, $8.0B calculated opportunity. - HS 300290: 4 buyer markets, $3.0B calculated opportunity. - HS 300220: 3 buyer markets, $9.5B calculated opportunity. - HS 330300: 3 buyer markets, $4.4B calculated opportunity. - HS 300420: 2 buyer markets, $2.6B calculated opportunity. ## Method Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology). ## Data sources - Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/) - CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf) This page presents derived Yugalinks views of reported observations and calculated indicators.